Medical review (Berlin, Germany)最新文献

筛选
英文 中文
Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives. 位点特异性基因组编辑在遗传性疾病治疗中的应用:可能性、进展和前景。
Medical review (Berlin, Germany) Pub Date : 2022-11-11 eCollection Date: 2022-10-01 DOI: 10.1515/mr-2022-0029
Chao Huang, Qing Li, Jinsong Li
{"title":"Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives.","authors":"Chao Huang,&nbsp;Qing Li,&nbsp;Jinsong Li","doi":"10.1515/mr-2022-0029","DOIUrl":"10.1515/mr-2022-0029","url":null,"abstract":"<p><p>Advancements in genome editing enable permanent changes of DNA sequences in a site-specific manner, providing promising approaches for treating human genetic disorders caused by gene mutations. Recently, genome editing has been applied and achieved significant progress in treating inherited genetic disorders that remain incurable by conventional therapy. Here, we present a review of various programmable genome editing systems with their principles, advantages, and limitations. We introduce their recent applications for treating inherited diseases in the clinic, including sickle cell disease (SCD), β-thalassemia, Leber congenital amaurosis (LCA), heterozygous familial hypercholesterolemia (HeFH), etc. We also discuss the paradigm of <i>ex vivo</i> and <i>in vivo</i> editing and highlight the promise of somatic editing and the challenge of germline editing. Finally, we propose future directions in delivery, cutting, and repairing to improve the scope of clinical applications.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 5","pages":"471-500"},"PeriodicalIF":0.0,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b4/9e/mr-2-5-mr-2022-0029.PMC10388762.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10657919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Developmental origins of adult diseases. 成人疾病的发育起源。
Medical review (Berlin, Germany) Pub Date : 2022-11-11 eCollection Date: 2022-10-01 DOI: 10.1515/mr-2022-0027
Jiaying Mo, Xuanqi Liu, Yutong Huang, Renke He, Yu Zhang, Hefeng Huang
{"title":"Developmental origins of adult diseases.","authors":"Jiaying Mo,&nbsp;Xuanqi Liu,&nbsp;Yutong Huang,&nbsp;Renke He,&nbsp;Yu Zhang,&nbsp;Hefeng Huang","doi":"10.1515/mr-2022-0027","DOIUrl":"10.1515/mr-2022-0027","url":null,"abstract":"<p><p>The occurrence and mechanisms of developmental adult diseases have gradually attracted attention in recent years. Exposure of gametes and embryos to adverse environments, especially during plastic development, can alter the expression of certain tissue-specific genes, leading to increased susceptibility to certain diseases in adulthood, such as diabetes, cardiovascular disease, neuropsychiatric, and reproductive system diseases, etc. The occurrence of chronic disease in adulthood is partly due to genetic factors, and the remaining risk is partly due to environmental-dependent epigenetic information alteration, including DNA methylation, histone modifications, and noncoding RNAs. Changes in this epigenetic information potentially damage our health, which has also been supported by numerous epidemiological and animal studies in recent years. Environmental factors functionally affect embryo development through epimutation, transmitting diseases to offspring and even later generations. This review mainly elaborated on the concept of developmental origins of adult diseases, and revealed the epigenetic mechanisms underlying these events, discussed the theoretical basis for the prevention and treatment of related diseases.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 5","pages":"450-470"},"PeriodicalIF":0.0,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/80/62/mr-2-5-mr-2022-0027.PMC10388800.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10658303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Organoid research on human early development and beyond. 人类早期发育及以后的类器官研究。
Medical review (Berlin, Germany) Pub Date : 2022-10-31 eCollection Date: 2022-10-01 DOI: 10.1515/mr-2022-0028
Lu Wen, Fuchou Tang
{"title":"Organoid research on human early development and beyond.","authors":"Lu Wen,&nbsp;Fuchou Tang","doi":"10.1515/mr-2022-0028","DOIUrl":"10.1515/mr-2022-0028","url":null,"abstract":"<p><p>The organoid field has been developing rapidly during the last decade. Organoids for human pre-, peri- and post-implantation development have opened an avenue to study these biological processes <i>in vitro</i>, which have been hampered by lack of accessible research models for long term. The technologies of four fields, single cell omics sequencing, genome editing and lineage tracing, microfluidics and tissue engineering, have fueled the rapid development of the organoid field. In this review, we will discuss the organoid research on human early development as well as future directions of the organoid field combining with other powerful technologies.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 5","pages":"512-523"},"PeriodicalIF":0.0,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/26/mr-2-5-mr-2022-0028.PMC10471100.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10657922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound contrast agents from microbubbles to biogenic gas vesicles. 超声造影剂从微泡到生物气泡。
Medical review (Berlin, Germany) Pub Date : 2022-10-19 eCollection Date: 2023-02-01 DOI: 10.1515/mr-2022-0020
Wenlong Zeng, Xiuli Yue, Zhifei Dai
{"title":"Ultrasound contrast agents from microbubbles to biogenic gas vesicles.","authors":"Wenlong Zeng, Xiuli Yue, Zhifei Dai","doi":"10.1515/mr-2022-0020","DOIUrl":"10.1515/mr-2022-0020","url":null,"abstract":"<p><p>Microbubbles have been the earliest and most widely used ultrasound contrast agents by virtue of their unique features: such as non-toxicity, intravenous injectability, ability to cross the pulmonary capillary bed, and significant enhancement of echo signals for the duration of the examination, resulting in essential preclinical and clinical applications. The use of microbubbles functionalized with targeting ligands to bind to specific targets in the bloodstream has further enabled ultrasound molecular imaging. Nevertheless, it is very challenging to utilize targeted microbubbles for molecular imaging of extravascular targets due to their size. A series of acoustic nanomaterials have been developed for breaking free from this constraint. Especially, biogenic gas vesicles, gas-filled protein nanostructures from microorganisms, were engineered as the first biomolecular ultrasound contrast agents, opening the door for more direct visualization of cellular and molecular function by ultrasound imaging. The ordered protein shell structure and unique gas filling mechanism of biogenic gas vesicles endow them with excellent stability and attractive acoustic responses. What's more, their genetic encodability enables them to act as acoustic reporter genes. This article reviews the upgrading progresses of ultrasound contrast agents from microbubbles to biogenic gas vesicles, and the opportunities and challenges for the commercial and clinical translation of the nascent field of biomolecular ultrasound.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"3 1","pages":"31-48"},"PeriodicalIF":0.0,"publicationDate":"2022-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/00/mr-3-1-mr-2022-0020.PMC10471104.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10363192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trimethylamine-N-oxide is an important target for heart and brain diseases. 三甲胺-N-氧化物是心脑疾病的重要靶点。
Medical review (Berlin, Germany) Pub Date : 2022-09-22 eCollection Date: 2022-08-01 DOI: 10.1515/mr-2022-0026
Shusi Ding, Jing Xue, Qi Zhang, Lemin Zheng
{"title":"Trimethylamine-N-oxide is an important target for heart and brain diseases.","authors":"Shusi Ding,&nbsp;Jing Xue,&nbsp;Qi Zhang,&nbsp;Lemin Zheng","doi":"10.1515/mr-2022-0026","DOIUrl":"10.1515/mr-2022-0026","url":null,"abstract":"Trimethylamine-N-oxide (TMAO) is a metabolite produced","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 4","pages":"321-323"},"PeriodicalIF":0.0,"publicationDate":"2022-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c3/cc/mr-2-4-mr-2022-0026.PMC10388736.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10311415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The polarizable and reprogrammable identity of Kupffer cells in Nonalcoholic Steatohepatitis. Kupffer细胞在非酒精性脂肪性肝炎中的可极化和可重编程特性。
Medical review (Berlin, Germany) Pub Date : 2022-09-20 eCollection Date: 2022-08-01 DOI: 10.1515/mr-2022-0023
Tarik Zahr, Kevin Sun, Li Qiang
{"title":"The polarizable and reprogrammable identity of Kupffer cells in Nonalcoholic Steatohepatitis.","authors":"Tarik Zahr,&nbsp;Kevin Sun,&nbsp;Li Qiang","doi":"10.1515/mr-2022-0023","DOIUrl":"10.1515/mr-2022-0023","url":null,"abstract":"<p><p>Kupffer cells (KCs) are the resident macrophages of the liver with similar origins to myeloid-derived macrophages. Once differentiated, KCs exhibit distinct cellular machinery capable of longevity and self-renewal, making them a crucial player in promoting effective intrahepatic communication. However, this gets compromised in disease states like Nonalcoholic Steatohepatitis (NASH), where the loss of embryo-derived KCs (EmKCs) is observed. Despite this, other KC-like and KC-derived populations start to form and contribute to a variety of roles in NASH pathogenesis, often adopting a NASH-associated molecular signature. Here we offer a brief overview of recent reports describing KC polarization and reprogramming in the liver. We describe the complexities of KC cellular identity, their proposed ability to reprogram to fibroblast-like and endothelial-like cells, and the potential implications in NASH.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 4","pages":"324-327"},"PeriodicalIF":0.0,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/c7/mr-2-4-mr-2022-0023.PMC10388795.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10311416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crosstalk between bone and other organs. 骨骼和其他器官之间的串扰。
Medical review (Berlin, Germany) Pub Date : 2022-09-15 eCollection Date: 2022-08-01 DOI: 10.1515/mr-2022-0018
Wanqiong Yuan, Chunli Song
{"title":"Crosstalk between bone and other organs.","authors":"Wanqiong Yuan,&nbsp;Chunli Song","doi":"10.1515/mr-2022-0018","DOIUrl":"10.1515/mr-2022-0018","url":null,"abstract":"<p><p>Bone has long been considered as a silent organ that provides a reservoir of calcium and phosphorus, traditionally. Recently, further study of bone has revealed additional functions as an endocrine organ connecting systemic organs of the whole body. Communication between bone and other organs participates in most physiological and pathological events and is responsible for the maintenance of homeostasis. Here, we present an overview of the crosstalk between bone and other organs. Furthermore, we describe the factors mediating the crosstalk and review the mechanisms in the development of potential associated diseases. These connections shed new light on the pathogenesis of systemic diseases and provide novel potential targets for the treatment of systemic diseases.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 4","pages":"331-348"},"PeriodicalIF":0.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/24/mr-2-4-mr-2022-0018.PMC10471111.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10311417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Proteomics research of SARS-CoV-2 and COVID-19 disease. SARS-CoV-2和新冠肺炎疾病的蛋白质组学研究。
Medical review (Berlin, Germany) Pub Date : 2022-09-14 eCollection Date: 2022-08-01 DOI: 10.1515/mr-2022-0016
Nan Zhang, Siyuan Wang, Catherine C L Wong
{"title":"Proteomics research of SARS-CoV-2 and COVID-19 disease.","authors":"Nan Zhang,&nbsp;Siyuan Wang,&nbsp;Catherine C L Wong","doi":"10.1515/mr-2022-0016","DOIUrl":"10.1515/mr-2022-0016","url":null,"abstract":"<p><p>Currently, coronavirus disease 2019 (COVID-19) is still spreading in a global scale, exerting a massive health and socioeconomic crisis. Deep insights into the molecular functions of the viral proteins and the pathogenesis of this infectious disease are urgently needed. In this review, we comprehensively describe the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and summarize their protein interaction map with host cells. In the protein interaction network between the virus and the host, a total of 787 host prey proteins that appeared in at least two studies or were verified by co-immunoprecipitation experiments. Together with 29 viral proteins, a network of 1762 proximal interactions were observed. We also review the proteomics results of COVID-19 patients and proved that SARS-CoV-2 hijacked the host's translation system, post-translation modification system, and energy supply system via viral proteins, resulting in various immune disorders, multiple cardiomyopathies, and cholesterol metabolism diseases.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 4","pages":"427-445"},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/57/66/mr-2-4-mr-2022-0016.PMC10388787.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10311418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypothalamic GABAergic neurocircuitry in the regulation of energy homeostasis and sleep/wake control. 下丘脑GABA能神经回路在能量稳态调节和睡眠/觉醒控制中的作用。
Medical review (Berlin, Germany) Pub Date : 2022-09-14 eCollection Date: 2022-10-01 DOI: 10.1515/mr-2022-0022
Hong Jiang
{"title":"Hypothalamic GABAergic neurocircuitry in the regulation of energy homeostasis and sleep/wake control.","authors":"Hong Jiang","doi":"10.1515/mr-2022-0022","DOIUrl":"10.1515/mr-2022-0022","url":null,"abstract":"<p><p>Gamma-aminobutyric acid (GABAergic) neuron, as one of important cell types in synaptic transmission, has been widely involved in central nervous system (CNS) regulation of organismal physiologies including cognition, emotion, arousal and reward. However, upon their distribution in various brain regions, effects of GABAergic neurons in the brain are very diverse. In current report, we will present an overview of the role of GABAergic mediated inhibitory neurocircuitry in the hypothalamus, underlying mechanism of feeding and sleep homeostasis as well as the characteristics of latest transcriptome profile in order to call attention to the GABAergic system as potentially a promising pharmaceutical intervention or a deep brain stimulation target in eating and sleep disorders.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 5","pages":"531-540"},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/4d/mr-2-5-mr-2022-0022.PMC10388747.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10675081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Fibroblast growth factor 21 and dietary interventions: what we know and what we need to know next. 成纤维细胞生长因子21和饮食干预:我们所知道的和接下来需要知道的。
Medical review (Berlin, Germany) Pub Date : 2022-09-13 eCollection Date: 2022-10-01 DOI: 10.1515/mr-2022-0019
Tianru Jin
{"title":"Fibroblast growth factor 21 and dietary interventions: what we know and what we need to know next.","authors":"Tianru Jin","doi":"10.1515/mr-2022-0019","DOIUrl":"10.1515/mr-2022-0019","url":null,"abstract":"<p><p>Dietary interventions include the change of dietary styles, such as fasting and dietary or nutrient restrictions; or the addition of plant-derived compounds (such as polyphenols known as curcumin, resveratrol, or anthocyanin, or other nutraceuticals) into the diet. During the past a few decades, large number of studies have demonstrated therapeutic activities of these dietary interventions on metabolic and other diseases in human subjects or various animal models. Mechanisms underlying those versatile therapeutic activities, however, remain largely unclear. Interestingly, recent studies have shown that fibroblast growth factor 21 (FGF21), a liver-derived hormone or hepatokine, mediates metabolic beneficial effects of certain dietary polyphenols as well as protein restriction. Here I have briefly summarized functions of FGF21, highlighted related dietary interventions, and presented literature discussions on role of FGF21 in mediating function of dietary polyphenol intervention and protein restriction. This is followed by presenting my perspective view, with the involvement of gut microbiota. It is anticipated that further breakthroughs in this field in the near future will facilitate conceptual merge of classical medicine and modern medicine.</p>","PeriodicalId":74151,"journal":{"name":"Medical review (Berlin, Germany)","volume":"2 5","pages":"524-530"},"PeriodicalIF":0.0,"publicationDate":"2022-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/49/mr-2-5-mr-2022-0019.PMC10388781.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10657921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信